Congress won’t include PhRMA-backed Medicare change in opioids package
(By Nicholas Florko and Lev Facher for STAT) WASHINGTON — The latest version of a bill to address the opioid
Read More
Legislative Update
Senate passes bill to ban ‘gag clauses’ and free pharmacists to discuss drug pricing options
(By Nicholas Florko for STAT) WASHINGTON — The Senate on Monday overwhelmingly passed a bill that would let pharmacists inform
Read MoreSenators Unveil Legislation To Protect Patients Against Surprise Medical Bills
(By Rachel Bluth for Kaiser Health News) With frustration growing among Americans who are being charged exorbitant prices for medical
Read MoreWhat’s in, what’s out, and what’s still on the table in the opioids package passed by the Senate
(By Lev Facher for STAT) WASHINGTON — The Senate on Monday passed a wide-ranging opioids bill, one that aims to
Read MoreInsurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore
(By Blake Farmer, Nashville Public Radio in partnership that includes, NPR and Kaiser Health News) The largest insurer in Tennessee
Read MoreWhat’s in, what’s out, and what’s still on the table as the Senate is poised to vote on an opioids package
(By Lev Facher for STAT) WASHINGTON — The Senate will vote this week on a bill to prevent illicit fentanyl trafficking, account
Read MoreSenate votes to ban pharmacy gag clauses: 5 things to know
(By Alia Paavola for Becker’s Hospital Review) In an effort to increase drug price transparency, the Senate passed a bill
Read MoreThe Senate could soon pass an opioids package. But a new law is still a long way away
(By Lev Facher for STAT) WASHINGTON — The Senate is likely to pass a comprehensive bill to address the opioid
Read MoreNew Illinois law will prohibit nonmedical switching beginning January 1st.
The state of Illinois passed a law that will limit the practice of so-called nonmedical switching – in which insurance
Read MoreWhat price will be used when drug prices are required in direct to consumer ads?
The U.S. Senate passed an amendment to the spending bill that would require pharma companies to disclose the prices of
Read More